CD163 (MRQ-26)

cd163-mrq-26

This antibody is intended for in vitro diagnostic (IVD) use. The Cell Marque CD163 (MRQ-26) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. Use of this antibody is indicated, subsequent to clinical differential diagnosis, as an aid in the identification of monocytes and macrophages and diagnosis of monocytic neoplasms such as chronic myelomonocytic leukemia within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

Instructions For Use (IFU)

Leica Biosystems has not validated the performance characteristics of the Cell Marque products on the BOND and BOND-MAX analyzers. For performance data, MSDS sheets and technical trouble-shooting please contact Cell Marque directly.

  • PA0794
    7ml CD163 (MRQ-26 Mab) 'CM'

Product Specifications

Product Specifications

PA0794
7ml

Documents

Documents

Resources

Resources

This antibody is intended for in vitro diagnostic (IVD) use. The Cell Marque CD163 (MRQ-26) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. Use of this antibody is indicated, subsequent to clinical differential diagnosis, as an aid in the identification of monocytes and macrophages and diagnosis of monocytic neoplasms such as chronic myelomonocytic leukemia within the context of an antibody panel, the patient’s clinical history, and other diagnostic tests evaluated by a qualified pathologist.

Instructions For Use (IFU)

Leica Biosystems has not validated the performance characteristics of the Cell Marque products on the BOND and BOND-MAX analyzers. For performance data, MSDS sheets and technical trouble-shooting please contact Cell Marque directly.

Recently Viewed

View All